Trademark: 79097713
Status Date
Monday, December 21, 2020
Registration Number
4037134
Registration Date
Tuesday, October 11, 2011
Filing Date
Tuesday, December 21, 2010
Published for Opposition
Tuesday, July 26, 2011
Cancellation Date
Monday, December 21, 2020
5 Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke
Nov 7, 2021
Notification Of Effect Of Cancellation Of Intl Reg Mailed
Nov 7, 2021
Death Of International Registration
Mar 8, 2019
Total Invalidation Processed By The Ib
Jan 31, 2019
Total Invalidation Of Reg Ext Protection Sent To Ib
Jan 31, 2019
Invalidation Processed
Jan 18, 2019
Total Invalidation Of Reg Ext Protection Created
May 18, 2018
Cancelled Section 71
Aug 4, 2016
New Representative At Ib Received
Jun 23, 2012
Notification Processed By Ib
Mar 22, 2012
Final Disposition Notice Sent To Ib
Mar 22, 2012
Final Disposition Processed
Nov 10, 2011
Grant Of Protection Created, To Be Sent To Ib
Oct 11, 2011
Registered-Principal Register
Jul 26, 2011
Published For Opposition
Jul 6, 2011
Notice Of Publication
Jun 25, 2011
Application Filing Receipt Mailed
Jun 23, 2011
Approved For Pub - Principal Register
Jun 21, 2011
Assigned To Examiner
Jun 21, 2011
New Application Office Supplied Data Entered In Tram
Jun 17, 2011
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
